Scroll Back to Top
Contact Us
Info Sheet

Innovative ocular solutions: Improving lives through advanced therapies

Download PDF

With a proud 30-year heritage as a leading CRO, Fortrea combines the rich legacy of Covance and Labcorp Drug Development with the specialized ophthalmology experience gained from Chiltern, in the 2017 acquisition. Our extensive experience spans multiple indications, from front and back-of-the-eye conditions to rare ocular diseases, cell and gene therapies, pediatrics, and ophthalmic devices and diagnostics.

Book a Meeting

Choose how you like to connect.

We've been driving innovation with our tailored clinical solutions for 30+ years. Let's connect.

Write to us
Book a Meeting

Prefer to send an inquiry?

Tell us about your needs and our team will follow up shortly.

* denotes required fields

Service Interest(s)
(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif, jpg, jpeg, png, bmp, txt, rtf, html, pdf, doc, docx, ppt, pptx, xls, xlsx, xml.

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Explore Careers at Fortrea

Join our Site Network

Learn more about participating in a Fortrea Clinical Trial

Need to speak directly with our sales team?

Connect with our sales team to discuss your needs and explore the right solutions for your clinical development goals — quick, clear, and hassle‑free.

Book a Meeting